MYGN

Myriad Genetics, Inc. News Headlines

$32.58
*  
0.20
0.62%
Get MYGN Alerts
*Delayed - data as of Nov. 24, 2014 11:04 ET  -  Find a broker to begin trading MYGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MYGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Myriad Genetics, Tesaro Tie Up for myChoice Cancer Test - Analyst Blog
11/21/2014 3:10:00 PM - Zacks.com


Myriad's Vectra DA: A Better Indicator for Rheumatoid Arthritis - Analyst Blog
11/20/2014 3:00:00 PM - Zacks.com


TESARO, Myriad Announce Companion Diagnostics Collaboration - Quick Facts
11/20/2014 8:23:00 AM - RTT News


Update: Myriad Genetics Q1 FY 2015 Earnings
11/15/2014 8:30:00 AM - Seeking Alpha


Myriad Genetics To Present At Credit Suisse Conference; Webcast At 3:00 PM ET
11/12/2014 2:00:00 PM - RTT News


Myriad Genetics Down on Earnings, Revenue Miss in Q1 - Analyst Blog
11/6/2014 3:30:00 PM - Zacks.com


Wall Street Seeking To Regain Momentum
11/5/2014 6:30:00 AM - RTT News


Myriad Genetics Q1 Results Miss Estimates, Issues Weak Q2 Outlook
11/4/2014 10:01:00 PM - RTT News


Myriad Genetics Q1 Profit Decreases - Quick Facts
11/4/2014 6:08:00 PM - RTT News


Myriad Genetics Q1 15 Earnings Conference Call At 4:30 PM ET
11/4/2014 3:00:00 PM - RTT News


Earnings Reaction History: Myriad Genetics Inc., 33.3% Follow-Through Indicator, 6.5% Sensitive
11/4/2014 2:34:44 PM - MT Newswires


Weakness Seen in Myriad (MYGN): Stock Tumbles 7.2% - Tale of the Tape
10/20/2014 8:14:18 AM - Zacks.com


Myriad Genetics Breaks Below 200-Day Moving Average - Notable for MYGN
10/17/2014 10:50:40 AM - BNK Invest


Novavax (NVAX) Moves Up: Stock Adds 10.1% in Session - Tale of the Tape
10/17/2014 8:39:00 AM - Zacks.com


Lexicon Pharmaceuticals (LXRX) Jumps: Stock Rises 15.7% - Tale of the Tape
10/17/2014 7:51:00 AM - Zacks.com


Interesting MYGN Call Options For October 18th
10/16/2014 9:44:48 AM - BNK Invest


Peregrine Pharmaceuticals (PPHM) Jumps: Stock Rises 10.7% - Tale of the Tape
10/16/2014 8:39:00 AM - Zacks.com


Should Genomic Health (GHDX) Be in Your Portfolio Now? - Analyst Blog
10/15/2014 5:52:00 PM - Zacks.com


Wall Street Stays Positive Ahead Of Jobless Claims Data
10/9/2014 6:30:00 AM - RTT News


Chuck Royce Comments on Myriad Genetics
10/8/2014 4:18:29 PM - GuruFocus


Myriad Names Bryan Riggsbee CFO - Quick Facts
10/8/2014 4:18:00 PM - RTT News


An Undervalued Medical Stock At The Forefront Of Predictive Medicine
10/8/2014 8:30:00 AM - Investopedia


A Cutting-Edge Medical Stock That's Incredibly Undervalued
10/8/2014 8:30:00 AM - Investopedia


Myriad Genetics Poised on Strong myRisk, Overseas Results - Analyst Blog
9/26/2014 2:20:00 PM - Zacks.com


Cramer's Mad Money - The World Is Slowing, And Slowing Fast (9/16/14)
9/17/2014 5:29:00 AM - Seeking Alpha